Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
companyunderground
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
»
Companies
» Company Monitoring Page for Pfizer
Company Monitoring Page for Pfizer
latest headlines for company on cafepharma
A Sensible Acquisition by This Healthcare Company
Motley Fool
Fri, 08/16/13 - 09:20 am
Tags:
M&A
,
Pfizer
,
Medicines Company
,
Fibrocaps
,
Endo Health Solutions
Pfizer, Sanford-Burnham Team Up on Obesity, Diabetes Target Research
GenEngNews
Wed, 08/14/13 - 10:23 am
Tags:
Pfizer
,
Sanford-Burnham Medical Research Institute
,
R&D
,
obesity
,
diabetes
Novartis, Pfizer Said to Be Out of Bidding for Onyx
Bloomberg
Wed, 08/14/13 - 10:19 am
Tags:
Novartis
,
Pfizer
,
ONYX Pharmaceuticals
,
Amgen
,
M&A
FDA Delivers a Double Dose of Good News in the Fight Against HIV
Motley Fool
Wed, 08/14/13 - 09:15 am
Tags:
FDA
,
HIV
,
Alere
,
Alere Determine
,
Tivicay
,
vaccines
,
ViiV Healthcare
,
GSK
,
Shionogi
,
Pfizer
[video]Time to Panic About Pfizer's Upcoming Patent Expirations?
Motley Fool
Wed, 08/14/13 - 09:11 am
Tags:
patents
,
Pfizer
The Next Big Opportunity in Antidepressant Drugs
Motley Fool
Tue, 08/13/13 - 11:08 am
Tags:
antidepressants
,
Pfizer
,
Eli Lilly
,
Forest Labs
,
Cymbalta
,
Fetzima
,
Pristiq
,
major depressive disorder
How Much To Develop A Drug? An Update
Seeking Alpha
Mon, 08/12/13 - 11:51 am
Tags:
R&D
,
AstraZeneca
,
Bayer
,
Eli Lilly
,
Novartis
,
Pfizer
,
Regeneron
,
Roche
,
Shire
,
Takeda
Pfizer And Merck Show Revenue Declines; Pipelines Remain Strong
Seeking Alpha
Mon, 08/12/13 - 10:20 am
Tags:
Pfizer
,
Merck
,
earnings
Pfizer's Earnings Made Easy
Motley Fool
Sat, 08/10/13 - 12:40 pm
Tags:
Pfizer
,
earnings
Regeneron: Q2 Results And Eylea Data Support The Long-Term Thesis
Seeking Alpha
Fri, 08/9/13 - 04:57 pm
Tags:
earnings
,
Regeneron
,
Eylea
,
Amgen
,
Novartis
,
Pfizer
,
Sanofi
Sun Pharmaceutical Profit Surges Before Pfizer Settlement Charge
Bloomberg
Fri, 08/9/13 - 09:41 am
Tags:
Sun Pharma
,
earnings
,
Pfizer
Pfizer Moves Up In Market Cap Rank, Passing IBM
Forbes
Thu, 08/8/13 - 08:14 am
Tags:
Pfizer
Pfizer to Pay $1.8 Million in Prempro Punitive Damages
Bloomberg
Wed, 08/7/13 - 04:05 pm
Tags:
Pfizer
,
Prempro
Zoetis 2nd-quarter net income falls 26 percent as company separated from former parent Pfizer
Yahoo/AP
Wed, 08/7/13 - 09:11 am
Tags:
earnings
,
animal health
,
Pfizer
,
Zoetis
The 5 Best-Selling Medications of 2013 (So Far)
Motley Fool
Tue, 08/6/13 - 11:24 am
Tags:
AbbVie
,
Humira
,
Advair
,
GSK
,
Seretide
,
Enbrel
,
Amgen
,
Pfizer
,
Lantus
,
Sanofi
,
Avastin
,
Roche
Trius Acquired Last Week, Tetraphase Could Be Next
Seeking Alpha
Tue, 08/6/13 - 10:19 am
Tags:
Trius Therapeutics
,
M&A
,
Tetraphase Pharmaceuticals
,
Cubist Pharmaceuticals
,
Optimer Pharmaceuticals
,
Pfizer
Breast Cancer Risk May Rise With Blood Pressure Medicines
Bloomberg
Tue, 08/6/13 - 10:05 am
Tags:
breast cancer
,
Norvasc
,
calcium channel blockers
,
Pfizer
The Deal: Pfizer's 3-Way Split Preps Company Long Term
The Street
Sat, 08/3/13 - 10:17 am
Tags:
Pfizer
These Pharmaceutical Giants Are Teetering Dangerously Near The Patent Cliff
Motley Fool
Sat, 08/3/13 - 10:16 am
Tags:
Pfizer
,
Eli Lilly
,
Bristol-Myers Squibb
,
patent cliff
Pfizer to pay $491M to resolve drug marketing case
Yahoo/AP
Wed, 07/31/13 - 08:56 am
Tags:
Pfizer
,
off label
,
whistleblower lawsuits
Pages
« first
‹ previous
…
188
189
190
191
192
193
194
195
196
…
next ›
last »
last 30 twitter posts
current feelings about your job
job rating
*
1 - I hate my job
2
3
4
5
6
7 - I love my job
Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
please tell us why
*
your industry
*
your job title (optional)
your company
*
published
N/A
published
not published
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
an umbrella protects you from: rain, sand, hunger
*
Fill in the blank.